Navigation Links
Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
Date:10/13/2008

diseases and cancer.

Arana Therapeutics' innovative engineering technologies provide the basis for clinical development in the antibody space, a market which draws on high demand. Arana Therapeutics has the financial stability and management expertise to accelerate its clinical programs, and is on track to have at least 3 clinical stage assets within three years.

The pipeline consists of four lead drug programs: ART621 to treat severe rheumatoid arthritis and other inflammatory diseases; ART010 to treat osteoporosis and bone cancer; ART104 to treat solid tumours in colorectal cancer; and ART150 for lung cancer and melanoma. Additionally the company has earlier stage products in development for the treatment of a range of conditions including age related macular degeneration, psoriasis, colorectal cancer, and leukaemia.

Arana has recurring revenues from commercial and development partnerships with six international companies including GSK, CSL, Centocor (J&J) and Abbott Laboratories. For further information: http://www.arana.com.

Contact:

Vista Partners LLC

Jorden Lampos

(310) 744-5268

info@vistap.com

http://www.vistap.com


'/>"/>
SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Synvista Therapeutics to be Featured on Wallst.net
5. Provista Awards Agreement to Spheris
6. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
9. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
10. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
11. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN...tionsbytheU.S.BankruptcyCourtfortheDistrictofDelaw...untarypetitionfor,reliefunderChapter11oftheUnitedS... TheordersissuedbytheBankruptcyCourtallowthecompan...proceedings.Inparticular,the,companyreceivedinteri...
(Date:11/24/2009)...bleEnergyCorp.announcedtodaythatthecompanyandtheOd...arded$2millionbyWashingtonState,sCommunityEconomic...hiptoconstructthestate,sfirstspecialtybiochemicalb...twillsignificantlyspeedthedevelopmentofourbiorefin...eMarbleEnergyCEOKellyOgilvie."WearegratefultotheGo...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... April 8 Amsterdam,Molecular Therapeutics (Eurone...apy, is, as of today, part of the newly created Ne... that NYSE Euronext has selected our company,for t...ndex will increase,the visibility of listed biotec...erformance of our sector.", The index is publishe...
...Milestone Payment, CARLSBAD, Calif., April 8, 200...ounced today that Bristol-Myers,Squibb Company (NY...ies,collaboration as a development candidate. As a...payment. The two companies have an ongoing,collabo...protein convertase,subtilisin kexin 9 (PCSK9). The...
...2008 For a woman facing,gynecologic cancer surger...choose a gynecologic oncologist, a physician who h...eatment of cancers of the female reproductive,syst...lose proximity to,other major organs in the abdome...e reproductive organs can easily spread to the bla...
Other Biology Technology:Amsterdam Molecular Therapeutics Part of Next Biotech Index 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 3BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 4Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot 2
(Date:11/24/2009)...secrets of the earth,s history locked in its icy d...tle information on the environments that have been.... Now, a team of researchers from nine institution...$10 million dollars by the National Science Founda...rally. These scientists will drill through the Wes...
(Date:11/24/2009)... , The presence of increased body fat, and t...in the blood, hinders the loss and maintenance of ... University of Navarra conducted by Estbaliz Goyen... , The project, entitled "A nutrigenetic and nut... weight and inflammation," examines how the indivi...
(Date:11/23/2009)... Applied mathematicians dissected the morphology o...teristic long leaf with a saddle-like arc midsecti... simple cause of the lily,s fan-like shapeelastic ...ial growthwas revealed by using an equally simple ...g, a postdoctoral student at Harvard,s School of E...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 1Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 3Teens Young Adults Need More Milk 49386 1Teens Young Adults Need More Milk 49386 2Aerobically unfit young adults on road to diabetes in middle age 49381 1Aerobically unfit young adults on road to diabetes in middle age 49381 2
...research has shown that resveratrol, a common diet...tion that leads to most types of breast cancer, su...cancer prevention. ,Resveratrol is a natural subst...in extract form as a dietary supplement at most ma...to prevent the first step that occurs when estroge...
...incident that led to the death of 26 dolphins near...heds new light on the extent of the problems facin...iversity of Exeter and Cornwall Wildlife Trust, pu...ion , has revealed a disturbing rise in the number...ornish beaches. The frequency of these mammals, co...
... patients with aggressive non-Hodgkin,s lymphoma i...ed chemotherapy regimen, researchers say. , At th...uropean Society for Medical Oncology, a group head...ts that giving these patients chemotherapy every 2...ed treatment outcomes. , The standard regimen in ...
Other Biology News:Researchers identify cancer preventive properties in common vitamin supplement 2Study shows rise in Cornwall's dolphin, whale and porpoise deaths 2New treatment approach promising for lymphoma patients in the developing world 2
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
Captivate magnetic separator for six microtubes from Molecular Probes (Invitrogen)
Protein Purification Applications from Promega
...ibes the basic equipment required, principles and ... and detection. Methods such as radiometric and bi...included. Other topics covered are, the detection ...chains and the study of DNA binding of immobilized...
Biology Products: